Claranova The software publishing company is scheduled to release its full-year results.
Engie Engie has announced several organizational changes and appointments within its Executive Committee.
Entech Entech generated consolidated revenue of 76 million euros for fiscal year 2025, representing a 62% increase (pro rata temporis) compared to fiscal year 2024 (an exceptional 9-month period).
FDE In the first half of fiscal year 2025/2026, Française de l'Energie (FDE) reported consolidated revenue of 14.2 million euros, up 16.5% year-on-year.
Ipsos Ipsos has announced the appointment of Alexandre Boissy as Deputy CEO, effective April 7.
LNA Santé The dependency care specialist will report its full-year results.
NRJ Group The group posted a sharp increase in 2025 profit driven by non-recurring items, despite a more challenging operating environment marked by declining advertising revenue.
Quadient The intelligent automation platform will report its full-year results.
Showroomprivé The flash sales specialist is set to announce its full-year results.
Transgene Alongside its earnings release, the biotech firm noted that its 105 million euro capital raise has extended its cash runway through early 2028.
Trigano The leisure vehicle and equipment specialist will detail its first-half revenue.
Ipsos is one of the world's leading market research companies. Net sales break down by type of customer as follows:
- consumers (49.3%): dissemination of barometric studies (to monitor changes in brand awareness and image), studies to measure the effectiveness of advertising campaigns, market studies, etc. The group also provides media research (including positioning research and audience measurement research for the press, TV, radio and Internet);
- clients and employees (20.5%): including the development of recruitment site studies, employee engagement measures, quality measurement, customer satisfaction and retention;
- citizens (15.4%): dissemination of studies of public opinion trends, studies of changes in lifestyles, etc.;
- physicians and patients (14.8%): development of case studies of the physician network, customer segmentation and targeting, market evaluation, sales force effectiveness, patient flow and satisfaction, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (49.3%), Americas (35.2%) and Asia/Pacific (15.5%).
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
